Tim Heise

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients

Ele Ferrannini, Elza Muscelli, Silvia Frascerra et al. · Journal of Clinical Investigation · 2014 · 1.1K citations · Full text

Medicine, Endocrinology, Physiology +11

Shift to Fatty Substrate Utilization in Response to Sodium–Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes

Ele Ferrannini, Simona Baldi, Silvia Frascerra et al. · Diabetes · 2016 · 714 citations

Life Sciences, Endocrinology, Pharmacology +12

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

Marcus Lind, William H. Polonsky, Irl B. Hirsch et al. · JAMA · 2017 · 690 citations

Medicine, Endocrinology, Internal Medicine +17

Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes

Tim Heise, Leszek Nosek, Birgitte Rønn et al. · Diabetes · 2004 · 619 citations · Full text

Medicine, Endocrinology, Pharmacokinetics +17

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.

L Heinemann, R. Linkeschova, Klaus Rave et al. · Diabetes Care · 2000 · 477 citations · Full text

Medicine, Endocrinology, Pharmacology +15